• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Bright Health Group Inc. (Amendment)

    2/14/24 5:04:52 PM ET
    $BHG
    Medical Specialities
    Health Care
    Get the next $BHG alert in real time by email
    SC 13G/A 1 d791741dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 1)*

     

     

    NeueHealth, Inc.

    (Name of Issuer)

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    10920V 40

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 2 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    Bessemer Venture Partners IX L.P.

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    448,648

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    448,648

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    448,648

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    5.6% (1)

    12.   

    TYPE OF REPORTING PERSON

     

    PN

     

    (1)

    The percentage of shares beneficially owned as set forth in row 11 above is based on a total of 7,982,087 shares of Common Stock as of November 2, 2023, as reported by the Issuer in its Form 10-Q filed with the SEC on November 9, 2023.


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 3 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    Bessemer Venture Partners IX Institutional L.P.

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    359,437

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    359,437

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    359,437

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    4.5% (1)

    12.   

    TYPE OF REPORTING PERSON

     

    PN


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 4 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    Deer IX & Co. L.P.

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    999.086 (2)

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    808,085

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    999,086 (2)

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    12.5%(1)

    12.   

    TYPE OF REPORTING PERSON

     

    PN

     

    (2)

    Pursuant to a proxy arrangement between Deer X L.P. and Deer IX L.P., Deer IX L.P., its general partner Deer IX Ltd., and the directors of Deer IX Ltd. make voting decisions with respect to the 191,001 shares of the Issuer held in the aggregate by Bessemer Venture Partners Century Fund L.P. and Bessemer Venture Partners Century Institutional L.P.


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 5 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    Deer IX & Co. Ltd.

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    999,086 (2)

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    808,085

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    999,086 (2)

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    12.5% (1)

    12.   

    TYPE OF REPORTING PERSON

     

    CO


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 6 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    Bessemer Venture Partners Century Fund L.P.

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    26,129

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    26,129

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    26,129

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    0.3% (1)

    12.   

    TYPE OF REPORTING PERSON

     

    PN


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 7 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    Bessemer Venture Partners Century Fund Institutional L.P.

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    164,872

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    164,872

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    164,872

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    2.0% (1)

    12.   

    TYPE OF REPORTING PERSON

     

    PN


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 8 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    Deer X & Co. L.P.

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    0 (2)

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    191,001

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    191,001

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    2.3% (1)

    12.   

    TYPE OF REPORTING PERSON

     

    PN


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 9 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    Deer X & Co. Ltd.

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    0 (2)

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    191,001

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    191,001

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    2.3% (1)

    12.   

    TYPE OF REPORTING PERSON

     

    CO


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 10 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    15 Angels II LLC

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    132

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    132

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    132

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    0.0% (1)

    12.   

    TYPE OF REPORTING PERSON

     

    OO


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 11 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    Bessemer Venture Partners VIII Institutional L.P.

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    132

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    132

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    132

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    0.0% (1)

    12.   

    TYPE OF REPORTING PERSON

     

    PN


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 12 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    Deer VIII & Co. L.P.

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    132

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    132

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    132

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    0.0% (1)

    12.   

    TYPE OF REPORTING PERSON

     

    PN


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 13 of 21 Pages

     

     1.   

    NAMES OF REPORTING PERSONS

     

    Deer VIII & Co. Ltd.

     2.   

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐  (b) ☒

     

     3.   

    SEC USE ONLY

     

     4.   

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY  

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.   

    SOLE VOTING POWER

     

    132

        6.   

    SHARED VOTING POWER

     

    0

        7.   

    SOLE DISPOSITIVE POWER

     

    132

        8.   

    SHARED DISPOSITIVE POWER

     

    0

    9.   

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    132

    10.   

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

    ☐

    11.   

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    0.0% (1)

    12.   

    TYPE OF REPORTING PERSON

     

    CO


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 14 of 21 Pages

     

    Item 1.

    Issuer

    (a) Name of Issuer:

    NeueHealth, Inc. f/k/a Bright Health Group, Inc. (the “Issuer”)

    (b) Address of Issuer’s Principal Executive Offices:

    9250 NW 36th St Suite 420

    Doral, FL 33178

     

    Item 2(a).

    Name of Person Filing:

    This statement is being filed by the following persons with respect to certain shares of Common Stock (the “Shares” or the “Common Stock”) of the Issuer. Bessemer Venture Partners IX L.P. (“Bessemer IX”), Bessemer Venture Partners IX Institutional L.P. (“Bessemer Institutional”, and together with Bessemer IX, the “Bessemer IX Funds”), Bessemer Venture Partners Century Fund L.P. (“Bessemer Century”), Bessemer Venture Partners Century Fund Institutional L.P. (“Bessemer Century Institutional”, and together with Bessemer Century, the “Bessemer Century Funds”) and 15 Angels II LLC (“15 Angels”) directly own shares of Common Stock.

     

    (a)

    Deer IX & Co. Ltd. (“Deer IX Ltd”), the general partner of Deer IX & Co. L.P. (“Deer IX LP”);

     

    (b)

    Deer IX LP, the sole general partner of each of the Bessemer IX Funds;

     

    (c)

    Bessemer IX, which directly owns 448,648 Shares;

     

    (d)

    Bessemer Institutional which directly owns 359,437 Shares;

     

    (e)

    Deer X & Co. Ltd. (“Deer X Ltd”), the general partner of Deer X & Co. L.P. (“Deer X LP”);

     

    (f)

    Deer X LP, the sole general partner of the Bessemer Century Funds;

     

    (g)

    Bessemer Century, which directly owns 26,129 Shares;

     

    (h)

    Bessemer Century Institutional, which directly owns 164,872 Shares;

     

    (i)

    Deer VIII & Co. Ltd. (“Deer VIII Ltd”), the general partner of Deer VIII & Co. L.P. (“Deer VIII LP”);

     

    (j)

    Deer VIII LP, the sole general partner of Bessemer Venture Partners VIII Institutional L.P. (“Bessemer VIII Institutional”);

     

    (k)

    Bessemer VIII Institutional, the sole member of 15 Angels; and

     

    (l)

    15 Angels, which directly owns 132 Shares.

    Deer IX Ltd, Deer IX LP, Deer X Ltd, Deer X LP, Deer VIII Ltd, Deer VIII LP, Bessemer IX, Bessemer Institutional, Bessemer Century, Bessemer Century Institutional, Bessemer VIII Institutional and 15 Angels are sometimes individually referred to herein as a “Reporting Person” and collectively as the “Reporting Persons.”

     

    Item 2(b).

    Address of Principal Business Office or, if None, Residence:

    The address of the principal business office of each of the Reporting Persons:

    c/o Bessemer Venture Partners

    1865 Palmer Avenue; Suite 104

    Larchmont, NY 10583


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 15 of 21 Pages

     

    Item 2(c).

    Citizenship:

    Deer IX Ltd— Cayman Islands

    Deer IX LP — Cayman Islands

    Bessemer IX — Cayman Islands

    Bessemer Institutional — Cayman Islands

    Deer X Ltd— Cayman Islands

    Deer X LP — Cayman Islands

    Bessemer Century — Cayman Islands

    Bessemer Century Institutional — Cayman Islands

    Deer VIII Ltd— Cayman Islands

    Deer VIII LP — Cayman Islands

    Bessemer VIII Institutional — Cayman Islands

    15 Angels — Delaware

     

    Item 2(d).

    Title of Class of Securities:

    Common Stock, $0.0001 par value

     

    Item 2(e).

    CUSIP Number:

    10920V 40

     

    Item 3.

    Not Applicable. 

     

    Item 4.

    Ownership.

    For Deer IX Ltd:

     

      (a)

    Amount beneficially owned: 999,086 Shares

     

      (b)

    Percent of class: 12.5%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –999,086–

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –808,085–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–

    For Deer IX LP:

     

      (a)

    Amount beneficially owned: 999,086 Shares

     

      (b)

    Percent of class: 12.5%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –999,086–

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –808,085–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 16 of 21 Pages

     

    For Bessemer IX:

     

      (a)

    Amount beneficially owned: 448,648 Shares

     

      (b)

    Percent of class: 5.6%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –448,648–

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –448,648–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–

    For Bessemer Institutional:

     

      (a)

    Amount beneficially owned: 359,437 Shares

     

      (b)

    Percent of class: 4.5%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –359,437–

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –359,437–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–

    For Deer X Ltd:

     

      (a)

    Amount beneficially owned: 191,001 Shares

     

      (b)

    Percent of class: 2.3%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –0–

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –191,001–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–

    For Deer X LP:

     

      (a)

    Amount beneficially owned: 191,001 Shares

     

      (b)

    Percent of class: 2.3%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –0–

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –191,001–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 17 of 21 Pages

     

    For Bessemer Century:

     

      (a)

    Amount beneficially owned: 26,129 Shares

     

      (b)

    Percent of class: 0.3%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –26,129–

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –26,129–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–

    For Bessemer Century Institutional:

     

      (a)

    Amount beneficially owned: 164,872 Shares

     

      (b)

    Percent of class: 2.0%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –164,872–

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –164,872–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–

    For Deer VIII Ltd:

     

      (a)

    Amount beneficially owned: 132 Shares

     

      (b)

    Percent of class: 0.0%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –132–

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –132–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–

    For Deer VIII LP:

     

      (a)

    Amount beneficially owned: 132 Shares

     

      (b)

    Percent of class: 0.0%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –132–

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –132–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–

    For Bessemer VIII Institutional:

     

      (a)

    Amount beneficially owned: 132 Shares

     

      (b)

    Percent of class: 0.0%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –132–


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 18 of 21 Pages

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –132–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–

    For 15 Angels:

     

      (a)

    Amount beneficially owned: 132 Shares

     

      (b)

    Percent of class: 0.0%

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote: –132–

     

      (ii)

    Shared power to vote or to direct the vote: –0–

     

      (iii)

    Sole power to dispose or to direct the disposition of: –132–

     

      (iv)

    Shared power to dispose or to direct the disposition of: –0–

    The percentage of shares beneficially owned as set forth above is based on a total of 7,982,087 shares of Common Stock as of November 2, 2023, as reported by the Issuer in its Form 10-Q filed with the SEC on November 9, 2023.

    Pursuant to a proxy arrangement between Deer X LP and Deer IX LP, Deer IX LP, its general partner Deer IX Ltd., and the directors of Deer IX Ltd. make voting decisions with respect to the 191,001 shares of the Issuer held in the aggregate by Bessemer Century and Bessemer Century Institutional.

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    Not applicable.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    As the general partner of Deer IX LP, which in turn is the general partner the Bessemer IX Funds, Deer IX Ltd may be deemed to beneficially own 808, 085 Shares held directly by the Bessemer IX Funds and have the power to direct the dividends from or the proceeds of the sale of such Shares. Additionally, pursuant to the proxy arrangement described above, Deer X LP may be deemed to beneficially own 191,001 shares of the Issuer held by Bessemer Century and Bessemer Century Institutional.

    As the general partner of Deer X LP, which in turn is the general partner of the Bessemer Century Funds, Deer X Ltd may be deemed to beneficially own 191,001 Shares held directly by the Bessemer Century Funds and have the power to direct the dividends from or the proceeds of the sale of such Shares.

    As the general partner of Deer VIII LP, which in turn is the general partner of Bessemer VIII Institutional, which in turn is the sole member of 15 Angels, Deer VIII Ltd may be deemed to beneficially own 132 Shares held directly by 15 Angels and have the power to direct the dividends from or the proceeds of the sale of such Shares.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not applicable.

     

    Item 8.

    Identification and Classification of Members of the Group.

    Exhibit 2 sets forth information regarding the identity of members of a group. The Reporting Persons disclaim membership in a group and this report shall not be deemed an admission by any of the Reporting Persons that they are or may be members of a “group” for purposes of Rule 13d-5 or for any other purpose.


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 19 of 21 Pages

     

    Item 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    Item 10.

    Certification.

    Not applicable.


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 20 of 21 Pages

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 14, 2024

     

    DEER IX & CO. LTD.
    By:  

    /s/ Scott Ring

    Name: Scott Ring
    Title: General Counsel
    DEER IX & CO. L.P.
    By:   Deer IX & Co. Ltd, its General Partner
    By:  

    /s/ Scott Ring

      Name: Scott Ring
      Title: General Counsel
    BESSEMER VENTURE PARTNERS IX L.P.
    BESSEMER VENTURE PARTNERS IX INSTITUTIONAL L.P.
    By: Deer IX & Co. L.P., its General Partner
    By: Deer IX & Co., Ltd., its General Partner
    By:  

    /s/ Scott Ring

      Name: Scott Ring
      Title: General Counsel
    DEER X & CO. LTD.
    By:  

    /s/ Scott Ring

    Name: Scott Ring
    Title: General Counsel
    DEER X & CO. L.P.
    By: Deer X & Co. Ltd, its General Partner
    By:  

    /s/ Scott Ring

    Name: Scott Ring
    Title: General Counsel


    CUSIP No. 10920V107    SHCHEDULE 13G    Page 21 of 21 Pages

     

    BESSEMER VENTURE PARTNERS CENTURY FUND L.P.
    BESSEMER VENTURE PARTNERS CENTURY FUND INSTITUTIONAL L.P.
    By: Deer X & Co. L.P., its General Partner
    By: Deer X & Co., Ltd., its General Partner
    By:  

    /s/ Scott Ring

    Name: Scott Ring
    Title: General Counsel
    DEER VIII & CO. LTD.
    By:  

    /s/ Scott Ring

      Name: Scott Ring
      Title: General Counsel
    DEER VIII & CO. L.P.
    By: Deer VIII & Co. Ltd, its General Partner
    By:  

    /s/ Scott Ring

    Name: Scott Ring
    Title: General Counsel
    BESSEMER VENTURE PARTNERS VIII INSTITUTIONAL L.P.
    By: Deer VIII & Co. L.P., its General Partner
    By: Deer VIII & Co., Ltd., its General Partner
    By:  

    /s/ Scott Ring

    Name: Scott Ring
    Title: General Counsel
    15 ANGELS II LLC
    By:  

    /s/ Scott Ring

      Name: Scott Ring
      Title: Authorized Person
    Get the next $BHG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BHG

    DatePrice TargetRatingAnalyst
    10/11/2022Neutral → Underweight
    JP Morgan
    3/29/2022Overweight → Neutral
    JP Morgan
    3/4/2022$9.00 → $3.00Outperform → Sector Perform
    RBC Capital
    3/3/2022$4.00 → $2.00Underweight
    Morgan Stanley
    3/3/2022$5.00 → $3.50Neutral
    Goldman Sachs
    3/3/2022$5.50 → $4.00Overweight
    Barclays
    3/3/2022$10.00 → $5.00Overweight
    Piper Sandler
    3/2/2022Buy → Underperform
    BofA Securities
    More analyst ratings

    $BHG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Bright Health Group Adopts NeueHealth as Corporate Brand Name

      The Company will advance its value-driven, consumer-centric care model through its owned and affiliated clinics and provider enablement services Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG) today announced that it has adopted NeueHealth as its corporate brand name. This reflects the Company's ongoing focus on its NeueHealth business, which will continue driving long-term sustainable growth of its value-driven, consumer-centric care model, thereby increasing access to high-quality healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid. The Company's common stock will begin trading under the new ticker symbol "NEUE" on the New York Stock

      1/17/24 4:05:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Closes the Sale of its California Medicare Advantage Business to Molina Healthcare

      Completes final repayment on secured credit facility eliminating the Company's secured debt Further focuses on increasing access to value-driven healthcare for all populations across the ACA Marketplace, Medicare, and Medicaid through its continuing business, NeueHealth Reaffirms expectation for Adjusted EBITDA profitability in 2024 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it has successfully completed the sale of its California Medicare Advantage business, Brand New Day and Central Health Plan, to Molina Healthcare, Inc. ("Molina"). The sale closed, effective as of Januar

      1/2/24 4:30:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Strengthens Capital Position with Amendment to its Credit Facility, Impending Close of the Sale of its California Medicare Advantage Business

      Received all required regulatory approvals on the sale of the California Medicare Advantage business; the transaction is expected to close on or about January 1, 2024 Amended Company's secured credit facility to reduce the final repayment resulting in approximately $30 million in savings Meaningfully improves capital position to support continuing business, NeueHealth, a value-driven consumer care delivery and provider enablement business Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced that it entered into an amendment to its credit facility with J.P. Morgan that will reduce the final

      12/29/23 6:45:00 AM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    SEC Filings

    See more
    • Bright Health Group Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - Bright Health Group Inc. (0001671284) (Filer)

      1/24/24 5:09:44 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Inc. filed SEC Form 8-K: Financial Statements and Exhibits

      8-K - Bright Health Group Inc. (0001671284) (Filer)

      1/4/24 9:17:32 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Bright Health Group Inc. (0001671284) (Filer)

      1/2/24 4:32:58 PM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Leadership Updates

    Live Leadership Updates

    See more
    • Bright Health Group Appoints Jay Matushak as Chief Financial Officer

      Cathy Smith to Step Down to Pursue New Opportunity, Effective May 12, 2023 Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today announced that it has appointed Jay Matushak as the Company's next Chief Financial Officer, effective May 12, 2023. Mr. Matushak will succeed Cathy Smith, who is stepping down to pursue another opportunity. Mr. Matushak, a seasoned finance and operational executive with deep expertise in the healthcare business, joined Bright Health in 2021. He currently serves as Senior Vice President of Finance and is responsible

      5/3/23 5:00:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Announces Retirement of General Counsel Keith Nelsen

      Jeff Craig, lead counsel for the Company's NeueHealth business, named General Counsel and Corporate Secretary Bright Health Group, Inc. ("Bright Health" or "The Company") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that Keith Nelsen will retire as General Counsel and Corporate Secretary. Jeff Craig, lead counsel for the Company's NeueHealth business, will be promoted to the role of General Counsel and Corporate Secretary effective March 18, 2022. Nelsen will stay on as a senior advisor with the Company until June 30, 2022, to ensure a smooth transition. "Keith has been a key leader for many of our mi

      3/15/22 4:35:00 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Names Leading Healthcare Expert to Board

      Matthew Manders to Join as Independent Director Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the first technology-enabled, Fully Aligned system of care built for healthcare's consumer retail market, today announced that leading healthcare expert Matt Manders will join the company's Board as an independent director, effective March 1. Manders brings a wealth of diverse healthcare experience, focus on operational excellence, and expertise in consumer-driven healthcare. Most recently, he served as president of Cigna Corporation's Government and Solutions organization, part of a 30-plus-year career with the company. In this role, Manders led and managed Cigna's U.S. Government busi

      3/1/22 8:10:00 AM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Financials

    Live finance-specific insights

    See more
    • Bright Health Group Reports Third Quarter 2023 Results

      Q3'23 Revenue from Continuing Business of $269.4 million, up 39% year over year Value-Based Consumers served of 355,000, an increase of 208.7% on a comparable basis from last year on strong growth in Care Delivery Q3'23 Net Loss from Continuing Business of $479.3 million, including a $401.4 million non-cash Goodwill impairment charge; Positive Adjusted EBITDA of $1.2 million in Q3'23 Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial r

      11/7/23 6:45:00 AM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group to Host Third Quarter 2023 Earnings Conference Call on November 7, 2023

      Bright Health Group, Inc. ("Bright Health") (NYSE:BHG), the technology enabled, value-driven healthcare company, today announced it will report Third Quarter financial results before the financial markets open on Tuesday, November 7, 2023, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via Bright Health's Investor Relations page at investors.brighthe

      10/13/23 8:00:00 AM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group Reports Second Quarter 2023 Results

      Q2'23 Revenue from Continuing Business of $298.0 million, up 100% year over year Value-Based Consumers served of 371,000, an increase of 214% on a comparable basis from last year on strong growth in Care Delivery Q2'23 Net Loss from Continuing Business of $31.7 million; Positive Adjusted EBITDA of $6.4 million in Q2'23, positive Operating Income in Care Delivery and Care Solutions segments Maintaining expectation for 2023 consolidated Adjusted EBITDA profitability† Bright Health Group, Inc. ("Bright Health" or the "Company") (NYSE:BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported fi

      8/9/23 6:45:00 AM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Yang Rick

      4 - Bright Health Group Inc. (0001671284) (Issuer)

      12/21/23 5:05:33 PM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Walker Paul Edward

      4 - Bright Health Group Inc. (0001671284) (Issuer)

      12/21/23 5:04:41 PM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form 4 filed by Sandell Scott D

      4 - Bright Health Group Inc. (0001671284) (Issuer)

      12/21/23 5:02:52 PM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Bright Health Group downgraded by JP Morgan

      JP Morgan downgraded Bright Health Group from Neutral to Underweight

      10/11/22 12:28:36 PM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Group downgraded by JP Morgan

      JP Morgan downgraded Bright Health Group from Overweight to Neutral

      3/29/22 7:08:00 AM ET
      $BHG
      Medical Specialities
      Health Care
    • Bright Health Gr downgraded by RBC Capital with a new price target

      RBC Capital downgraded Bright Health Gr from Outperform to Sector Perform and set a new price target of $3.00 from $9.00 previously

      3/4/22 6:06:15 AM ET
      $BHG
      Medical Specialities
      Health Care

    $BHG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Bright Health Group Inc. (Amendment)

      SC 13G/A - NeueHealth, Inc. (0001671284) (Subject)

      2/14/24 5:04:52 PM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form SC 13D/A filed by Bright Health Group Inc. (Amendment)

      SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)

      2/14/24 9:37:57 AM ET
      $BHG
      Medical Specialities
      Health Care
    • SEC Form SC 13D/A filed by Bright Health Group Inc. (Amendment)

      SC 13D/A - Bright Health Group Inc. (0001671284) (Subject)

      12/22/23 4:34:44 PM ET
      $BHG
      Medical Specialities
      Health Care